Have We Changed the Outcome in Membranous Nephropathy : A Propensity Study on the Role of Immunosuppressive Therapy

Clinical Journal of the American Society of Nephrology, 07/11/2011

The study confirms that patient presenting characteristics and management regimens have changed significantly over time and the natural history of membranous nephropathy (MGN) has been altered. A study of propensity–matched patients confirms that current recommendations for immunosuppressive therapy (IS) have improved outcomes in MGN patients at high risk of progression.

Print Article Summary Cat 2 CME Report